Economics not on agenda for ESC guideline development

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.437, 2003-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Latest guideline updates from ESC and EACTS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 613, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Guideline Development for Office-Based Pharmacotherapies for Opioid Dependence

By Fiellin David A. Barthwell Andrea G.

Journal of Addictive Diseases, Vol. 22, Iss. 4, 2003-12 ,pp. : 109-120

Haworth Press

Access to resources Recommend Favorite

Health economics in drug development

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 412, 2003-01 ,pp. : 3-5

Adis International

Access to resources Recommend Favorite

New guidelines released by ESC

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 614, 2010-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

News from ESC

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 663, 2012-01 ,pp. : 4-5

Adis International

Access to resources Recommend Favorite